方法：我院在2008-06/2012-12期间共收治新生血管性青光眼患者44例，将其随机分成试验组(22例)和对照组(22例)，其中试验组给予改良小梁切除术进行治疗，对照组给予睫状体冷凝术进行治疗，对比分析两组患者的治疗效果及并发症等情况。

结果：经过治疗两组患者的眼压均较治疗前显著降低(P<0.01)，但是两组间差异不明显(P>0.05)。试验组治疗总有效21例(95%)，显著高于对照组16例(73%)，差异具有统计学意义(χ²=7.3789，P<0.05)。同时对照组并发症的发生率及严重程度均显著高于试验组(P<0.05)。

结论：对于新生血管性青光眼患者来说，改良小梁切除术可有效降低其眼压，显著提高治疗成功率，并减少不良反应的发生，是一种安全高效的方法，应在临床中推广应用。

METHODS: There were 44 cases of neovascular glaucoma enrolled during June 2008 to December 2012. They were randomly divided into experimental group(22 cases)and control group(22 cases). The experimental group were treated with the modified trabeculectomy, and the control group were treated with cyclocryotherapy. Therapeutic effect and complications between two groups were compared.

RESULTS: Introocular pressure in both groups were significantly lower after treatment than before treatment(P<0.01), but there was no obvious difference between two groups(P>0.05). The total effective 21 cases(95%)in experimental group was higher than that in the control group 16 cases(73%)and the difference had statistically significance(χ²=7.3789, P<0.05). At the same time, the incidence of complications and severity in control group were significantly higher than that in the experimental group(P<0.05).

CONCLUSION: For patients with neovascular glaucoma, modified trabeculectomy can effectively reduce the intraocular pressure, and significantly improve the treatment success rate, as well as reduce the occurrence of adverse reactions. It is a safe and effective method, so modified trabeculectomy should be applied widely in clinical practice.